ESC Professional Premium Access

Apolipoprotein B and the regression of lipidic plaque in statin-treated type 2 DM patients with coronary artery disease: the pre-specified sub-analysis from the OPTIMAL randomized controlled trial

Congress Presentation

About the speaker

Doctor Sayaka Funabashi

Kyorin University, Tokyo (Japan)
1 follower

8 more presentations in this session

Physician disagreement with treatment guidelines as a critical barrier to achieving low-density lipoprotein cholesterol targets in very high-risk patients: an implementation science study

Speaker: Associate Professor K. Cho (Gwangju, KR)

Thumbnail

Lipoprotein(a) and atherosclerotic cardiovascular disease in a Brazilian tertiary hospital population

Speaker: Doctor V. Zorzanelli Rocha (Sao Paulo, BR)

Thumbnail

Impact of glucose metabolism status on the relationship between remnant cholesterol and ischemic risk after percutaneous coronary intervention: a large-scale long-term cohort study from real-world

Speaker: Doctor K. Yan (Beijing, CN)

Thumbnail

Association between lipoprotein particle concentration and size and progression of coronary plaque: the MACS Longitudinal Coronary CT angiography study

Speaker: Doctor R. Quispe (Baltimore, US)

Thumbnail

The association of inflammation, triglycerides and lipoprotein(a) with cardiovascular events in the UK Biobank

Speaker: Doctor B. Tucker (Sydney, AU)

Thumbnail

Access the full session

Lipids as risk factors for cardiovascular disease

Speakers: Doctor S. Funabashi, Associate Professor K. Cho, Doctor V. Zorzanelli Rocha, Doctor K. Yan, Doctor R. Quispe...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations